AI Meets Robotics: Delhi Hospital Unveils Next-Gen Hybrid Cath Lab
Fortis Escorts New Delhi introduces the ARTIS pheno.vision, an AI-powered hybrid cath lab for precision cardiac and vascular treatments.
In a major technological breakthrough for cardiac care in India, a private hospital in New Delhi has installed the ARTIS pheno.vision, an AI-powered and robot-assisted hybrid Cath Lab. This advanced system integrates robotic angiography, artificial intelligence-driven imaging, and hybrid operating room capabilities to handle complex cardiac and vascular interventions with unprecedented precision.
The installation at Fortis Escorts, New Delhi, represents a significant leap in managing intricate cardiovascular conditions. By combining high-tech imaging with robotic assistance, the facility aims to strengthen its focus on minimally invasive treatment pathways, offering patients safer alternatives to traditional methods.
Enhanced Precision and Faster Recovery
The integration of 3D visualization and AI-powered tools is designed to assist medical teams during critical stages of procedural planning, image acquisition, and device navigation. For many patients, this hybrid environment allows for image-guided, minimally invasive approaches that can bypass the need for conventional open-heart surgeries.
The hospital noted that these advanced methods offer several life-changing benefits for appropriately selected patients, including:
- Reduced procedural trauma: Less invasive techniques mean less physical stress on the body.
- Shorter hospital stays: Faster recovery times allow patients to return home sooner.
- Lower complication risks: A significant reduction in the chances of infection and other procedure-related issues.
A Lifeline for High-Risk Patients
The LaHybrid Cath Lab is specifically engineered to manage cases that were previously considered too difficult or dangerous. This includes elderly patients, individuals with multiple comorbidities, or those with challenging anatomical structures.
One of the most critical advantages of this setup is its ability to host multidisciplinary teams. Because it functions as both an interventional and surgical space, doctors can transition seamlessly from a catheter-based procedure to a full surgical intervention within the same room if the patient's condition changes during the operation.
Expert Insights on the Technological Leap
Speaking at the launch, Dr. Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare, emphasized the mission to bring world-class cardiac care to India. He stated that the robotic hybrid cath lab marks a monumental leap, expanding patient access to cutting-edge therapies and enhancing safety for the most complex heart and vascular conditions.
Dr. Ashok Seth, Chairman of Cardiac Sciences at Fortis Healthcare, highlighted the practical benefits for high-risk scenarios. He noted that Fortis Escorts is currently the only corporate hospital to have integrated this specific technology. According to Dr. Seth:
"Robotic positioning, sharper AI-powered imaging, and a lower radiation dose will help us place devices more accurately in procedures such as TAVI and complex vascular interventions, and make these treatments safer for patients, which were once considered too complex."
Dr. Vikram Aggarwal, Regional Director of Operations at Fortis Healthcare, added that the new system provides clinicians with greater flexibility and confidence, ensuring that patients presenting with high-risk conditions receive timely and precise interventions.